A randomized phase II study of acyclovir for the prevention of chemotherapy-induced oral mucositis in patients undergoing autologous hematopoietic stem cell transplantation
To prove our hypothesis that acyclovir prophylaxis in autologous hematopoietic stem cell transplantation (AHSCT) recipients with hematologic malignancies (HM) reduces the incidence of chemotherapy-induced oral...
Source: BMC Oral Health - Category: Dentistry Authors: Junshik Hong, Hee-Kyung Park, Sung-Ho Chang, Ja Min Byun, Dong-Yeop Shin, Youngil Koh, Sung-Soo Yoon, Youngnim Choi and Inho Kim Tags: Research Source Type: research
More News: Acyclovir | Cancer & Oncology | Chemotherapy | Dentistry | Hematology | Stem Cell Therapy | Stem Cells | Study | Transplants | Zovirax